51-40-1
- Product Name：Norepinephrine Bitartrate
- Molecular Formula：C8H11NO3.C4H6O6
- Purity：99%
- Molecular Weight：319.268
Product Details;
CasNo： 51-40-1
Molecular Formula： C8H11NO3.C4H6O6
Appearance： White crystalline powder
Trustworthy Factory Supply High Purity 99% Norepinephrine Bitartrate 51-40-1 with the Best Price
- Molecular Formula:C8H11NO3.C4H6O6
- Molecular Weight:319.268
- Appearance/Colour:White crystalline powder
- Vapor Pressure:2.24E-21mmHg at 25°C
- Melting Point:102-104 °C
- Boiling Point:442.6 °C at 760 mmHg
- PKA:8.64(at 25℃)
- Flash Point:221.5 °C
- PSA：201.77000
- LogP:-1.33240
L-NORADRENALINE BITARTRATE(Cas 51-40-1) Usage
|
Uses |
Adrenergic (vasoconstrictor). |
|
Brand name |
Levophed (Hospira). |
|
Clinical Use |
Hypotension Cardiac arrest (sympathomimetic) |
|
Safety Profile |
Poison by intravenous andintraperitoneal routes. When heated to decomposition itemits toxic fumes of NOx. |
|
Drug interactions |
Potentially hazardous interactions with other drugs Adrenergic neurone blockers: antagonise hypotensive effect. Anaesthetics: increased risk of arrhythmias with volatile general anaesthetics. Antidepressants: tricyclics may cause hypertension and arrhythmias; MAOIs and moclobemide may cause hypertensive crisis. Beta-blockers: can cause severe hypertension. Clonidine: possibly increased risk of hypertension. Dopaminergics: effects possibly increased by entacapone; avoid with rasagiline. Sympathomimetics: effects possibly enhanced by dopexamine. |
|
Metabolism |
Extensively metabolised by catechol-O-methyltransferase (COMT), and monoamine oxidase (MAO). Up to 16% of an intravenous dose is excreted unchanged in the urine with methylated and deaminated metabolites in free and conjugated forms. |
InChI:InChI=1/C8H11NO3.C4H6O6/c9-4-8(12)5-1-2-6(10)7(11)3-5;5-1(3(7)8)2(6)4(9)10/h1-3,8,10-12H,4,9H2;1-2,5-6H,(H,7,8)(H,9,10)/t8-;/m1./s1
Relevant Products
-
Epinephrine bitartrateCAS：51-42-3
-
2-AminoadenosineCAS：209-61-0
-
dinotefuranCAS：165252-70-0
